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Commentary
The goal of this consortium (Fish Toxico­
genomics—Moving into Regulation and 
Monitoring, held 21–23 April 2008 at the 
Pacific Environmental Science Centre, 
Vancouver, BC, Canada) was to assess cur­
rent developments leading to the incorpora­
tion of omic technologies into environ mental 
risk assessment and environmental monitor­
ing, particularly in relation to aquatic eco­
toxicogenomics. Participants recognized that 
omic tools and associated end points are 
already significantly improving our understand­
ing of how individual chemicals and mixtures 
affect organisms and could ultimately influence 
risk assessment and environmental manage­
ment. Although a significant amount of basic 
research and validation is needed before omic 
end points are incorporated as complemen­
tary data for routine assessments of environ­
mental risk, participants generally agreed that 
there are no roadblocks for omics technology 
per se, but there are hurdles along the road of 
discovery, acceptance, and implementation 
of omic end points. Given the context of the 
workshop, it is important to note that “the 
successful incorporation of toxico genomics 
into regulatory frameworks may someday be 
regarded as the most important intellectual 
and practical contribution from this generation 
of eco toxicologists” (Ankley et al. 2006).
Benefits and Successful 
Applications of Omics in 
Ecotoxicology and Ecological 
Risk Assessments
Historical challenges and recent developments 
for regulatory implementation. Previous pub­
lications and workshops (e.g., Ankley et al. 
2006; Boverhof and Zacharewski 2006) have 
discussed the potential application of omic 
technologies to risk assessment. The use of 
omic technology in toxicology (toxico­
genomics) was initiated after the development 
of the first high­density techniques (micro­
arrays). However, excitement surrounding 
this new technology generated “hype” that 
yielded unrealistic expectations of the time­
line for incorporation into risk assessment. 
There is now a more realistic understand­
ing of the potential contribution of omics 
to toxicology [National Research Council 
(NRC) 2007]. A multi level systems biology 
approach to safety assessment—combining 
molecular­ (including mRNA, protein, and 
metabo lites), cellular­, tissue­, individual­, and 
population­level data—represents a power ful 
new multi disciplinary approach that identifies 
biomarkers with much­improved predictive 
capacity.
Many initial concerns and difficulties have 
been overcome. The high cost of micro arrays 
imposed severe restrictions on the number of 
doses, replicates, and time points assessed after 
chemical administration to biological systems. 
As a consequence, reported omic responses 
frequently reflected pathological change with 
no evident predictive value. Methodology 
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Background: In this commentary we present the findings from an international consortium 
on fish toxicogenomics sponsored by the U.K. Natural Environment Research Council (Fish 
Toxicogenomics—Moving into Regulation and Monitoring, held 21–23 April 2008 at the Pacific 
Environmental Science Centre, Vancouver, BC, Canada). 
oBjectives: The consortium from government agencies, academia, and industry addressed three 
topics: progress in ecotoxicogenomics, regulatory perspectives on roadblocks for practical imple-
mentation of toxicogenomics into risk assessment, and dealing with variability in data sets.
discussion: Participants noted that examples of successful application of omic technologies have 
been identified, but critical studies are needed to relate molecular changes to ecological adverse out-
come. Participants made recommendations for the manage ment of technical and biological varia-
tion. They also stressed the need for enhanced interdisciplinary training and communication as well 
as considerable investment into the generation and curation of appropriate reference omic data. 
conclusions: The participants concluded that, although there are hurdles to pass on the road to 
regulatory acceptance, omics technologies are already useful for elucidating modes of action of toxi-
cants and can contribute to the risk assessment process as part of a weight-of-evidence approach.
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has now been improved and costs reduced, 
and microarrays are commercially available 
for a range of species. In the context of fish 
transcriptomics, a special issue of the Journal 
of Fish Biology (Miller and Maclean 2008) 
reported the progress that has been made with 
non model organisms.
Successful prospective and diagnostic case 
studies. Transcriptomic experiments in aquatic 
toxicology have been diverse—encompassing 
different microarray platforms, test species, and 
exposure routes—emphasizing their use as case 
studies rather than standardized tools. This 
wide­ranging approach contributes to the elu­
cidation of mechanisms of toxicity, including 
dose–response relationships, differential spe­
cies sensitivity, and classification of chemical­ 
specific biological responses. This approach 
also provides leads for identification of novel 
biomarkers of exposure and adverse effect.
Omic and bioinformatic tools offer sub­
stantial promise for discovery of gene, pro­
tein, and/or metabolite alterations indicative 
of the mode of action (MOA) of chemicals 
and improved understanding of mechanisms 
in prospective studies (Ankley et al. 2006). 
Knowing the MOA can reduce uncertain­
ties in chemical risk assessments, providing, 
for example, a basis for extrapolating effects 
across species (Benson and Di Giulio 2007). 
There is ongoing debate as to the appropri­
ate role of biomarker data in ecological risk 
assessments (Forbes et al. 2006). Historically, 
most biomarker data employed in ecotoxicol­
ogy indicated exposure but had limited abil­
ity to predict deleterious effects meaningful to 
risk assessment, namely, survival, growth and 
develop ment, and reproduction (Forbes et al. 
2006), largely because of a lack of mechanistic 
knowledge concerning linkages between molec­
ular alterations and outcomes in the whole 
organism. Ideally, omics data would reflect 
both the MOA and deleterious outcome(s). 
To achieve this, the cascade of pathways asso­
ciated with toxicity must be defined, from a 
molecular initiating event (e.g., receptor bind­
ing) through subsequent biological alterations 
(reflected by omic and cellular changes) that 
culminate in a deleterious outcome (NRC 
2007). However, there is also potential for 
a contribution to understanding ecologi­
cal impacts. Furthermore, omic approaches 
can contribute to the reduction of animal use 
and the severity of treatments, as more subtle 
changes can be identified and a more complete 
assessment of the health of individual animals 
or cell cultures can be achieved.
A recent example of how a toxicity pathway 
approach can be used to establish quantitative 
linkages across biological levels of organiza­
tion was provided by Miller et al. (2007) and 
Ankley et al. (2008a), who investigated the 
consequences of molecular changes in the 
fish hypothalamic–pituitary–gonadal (HPG) 
axis in terms of reproductive and population 
effects. Production of vitellogenin (VTG), an 
oocyte lipoprotein produced in the liver of 
oviparous female vertebrates, can be affected 
by a range of signaling events that alter steroid 
hormone production and activity. Analysis of 
an integrated data set derived from fathead 
minnow (Pimephales promelas) reproduction 
studies, with five chemicals that decrease VTG 
and fecundity but affect the HPG axis through 
different discrete mechanisms, demonstrated 
robust associations between steroid and VTG 
concentrations in female fish. This was predic­
tive of egg production and, via modeling, could 
be used to tentatively forecast fathead minnow 
population status. Thus, through understand­
ing the biological pathways leading to vitello­
genesis, mechanistic molecular responses were 
successfully related to potential adverse out­
comes meaningful to risk assessors.
Omics data can be used in diagnostic 
studies to determine the efficacy of pollution 
remediation as part of a weight­of­evidence 
approach (Roling et al. 2007). Furthermore, 
omic profiling can be used to identify chemi­
cal causation of effects induced by complex 
mixtures (Garcia­Reyero et al. 2008a). For 
example, in studies with the fathead minnow, 
Filby et al. (2007) applied multiple quanti­
tative polymerase chain reaction (PCR) to 
identify diagnostic signatures from differ­
ent chemicals that induce the same pheno­
typic effects. The authors identified common 
features in the responses of fish exposed to 
estrogenic wastewater effluent and individual 
steroid estrogens. These data demon strate 
that patterns of gene expression induced by 
estrogenic effluents, although complex, can 
be diagnostic for some of the estrogens they 
contain and could be used by regulators to 
determine the primary contaminant.
The utility of omics in studies on environ­
mental sites. The influence of the local environ­
ment on the transcriptome or metabolome of 
an organism can be exploited in environmen­
tal monitoring to characterize the effects of 
anthropogenic stressors such as pollution. In 
European flounder (Platichthys flesus) (Falciani 
et al. 2008), transcriptomics and genetic algo­
rithm bioinformatic approaches were used 
to predict the site of origin of fish from the 
environment based on stress­responsive genes. 
Thus, although gene expression is affected 
by many environmental factors, a subset of 
genes with altered expression can inform on 
stress responses. The potential utility here is 
to improve biomarker identification and to 
identify patterns of gene expression associ­
ated with different types of pollution. Bundy 
et al. (2007) sampled an earthworm species 
(Lumbricus rubellus) from seven sites with dif­
ferent levels of metal contamination. Using 
nuclear magnetic resonance (NMR) metabo­
lomics, the authors showed that metabolic 
profiles of the earthworms could resolve indi­
vidual sites. Despite the confounding influences 
of site parameters, specific metabolites were 
correlated with zinc, the major contaminant, 
across all seven sites. Another NMR metabo­
lomics study involving flounder sampled from 
industrialized and reference sites in the United 
Kingdom showed that water composition had 
a significant effect on the fish liver metabo­
lome (Parsons et al. 2007). Uses of omic data 
for prognostic and diagnostic studies are sum­
marized in Supplemental Material, Table 1, 
available online (doi:10.1289/ehp.0900985.S1 
via http://dx.doi.org/). These important obser­
vations lend support to the implementation of 
omics as diagnostic tools in ecotoxicology.
Current Hurdles from a 
Regulatory Viewpoint
General technical hurdles in the application 
of toxicogenomics. Ankley et al. (2006) pro­
posed a time frame for realizing the utility of 
omics in tiered testing. However, a number of 
factors limit widespread acceptance for regu­
latory applications. In addition to complex 
relationships between omic responses and 
ecological outcome, standardized, validated 
exposure assay and analysis procedures are lack­
ing (Ankley et al. 2006). Omics technologies 
can be viewed as complementary testing pro­
cedures that can improve understanding of 
biological systems and can lead to develop­
ment of simpler individual assays with defined 
end points. This approach, although valuable, 
does not exploit the full capabilities of omics, 
particularly their open nature, allowing dis­
covery of unexpected changes. Intermediate 
technologies such as PCR arrays have been 
proposed for use in clinical diagnosis (Bustin 
and Mueller 2005) but are not open systems. 
The validation required for uptake of multi­
biomarker techniques for routine testing is 
time consuming and complex. In the clinical 
setting, some targeted microarray applications 
have now been approved by the U.S. Food 
and Drug Administration and the European 
Union for diagnostic use. These include the 
Amplichip CYP450 (Roche, Indianapolis, IN, 
USA) for genotyping of human cytochromes 
P450 and Mammaprint (Agendia, Amsterdam, 
the Netherlands), a gene­expression micro­
array for breast cancer prognosis (Glas et al. 
2006). Mammaprint validation required the 
testing of over 1,000 patient samples in 12,000 
assays, highlighting the effort and investment 
necessary for such accreditation. Validation 
of an assay is a complex procedure encom­
passing the determination of its reliability and 
relevance. Hartung et al (2004) discussed a 
modular approach to validating alternative tests 
as part of an initiative by the European Centre 
for Validation of Alternative Methods. This 
approach [see Supplemental Material, Figure 1 
(doi:10.1289/ehp.0900985.S1)] is applicable 
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in general terms to omics­based assays. Key to 
this procedure is defining a relevant end point. 
Biomarkers can be of exposure or of effect, 
and the choice between these biomarkers and 
the end points they aim to predict must be 
informed by the requirements of the regulators.
Corvi et al. (2006) suggested requirements 
for validation of transcriptomics in regula­
tory toxicology, but it is unlikely that this 
validation process will be rapid. However, 
a realis tic application of omics techniques 
may be their use in prescreening chemi cals 
and mixtures for prioritization in further 
tests (Ankley et al. 2006). The ToxCast pro­
gram (Dix et al. 2007) employed a diverse 
selection of tests, including toxicogenomics, 
and showed the potential application of this 
approach. The interpretation of omic data 
is highly reliant on advanced computational 
and statistical methods that are still being 
developed. Although quality assurance pro­
cedures are paramount, more flexibility is 
permitted at the pre screening tier. The U.S. 
Environmental Protection Agency (EPA 
2002) currently accepts toxicogenomics data 
as part of a weight­of­evidence approach for 
establishing mechanisms of toxicity for regu­
lated substances. Data capture and archiving 
are essential mechanisms for highlighting and 
avoiding the pitfalls of inappropriate experi­
mental design, such as the introduction of sys­
tematic variation during omics experiments. 
Although transcriptomics databases are well 
established, toxicology­specific omics data­
bases are now emerging (Waters et al. 2008).
Environmental metabolomics recently 
benefited from the first interlaboratory inter­
comparison exercise to evaluate the accuracy, 
precision, and efficacy of 1H NMR metabolo­
mics (Viant et al. 2009). Flounder liver extracts 
from contaminated and reference sites were 
analyzed, and multi variate statistical analyses 
confirmed high reproducibility across all seven 
laboratories involved in the study. Furthermore, 
the same metabolic biomarkers used to dif­
ferentiate fish from the two sites were discov­
ered by all the laboratories [see Supplemental 
Material (doi:10.1289/ehp.0900985.S1)]. For 
transcriptomics in fish, diversity of micro array 
platforms has precluded inter laboratory com­
parisons, but interlaboratory micro array com­
parison has been successful for mammalian 
species (e.g., Mattes 2008; Shi et al. 2006). It 
is likely that, in the future, improvements in 
the technologies for assaying gene expression, 
such as high­throughput pyro sequencing and 
digital transcriptomics (Nielsen et al. 2006), 
will replace microarrays. Already, pyrosequenc­
ing allows for fast construction of high­quality 
oligo nucleotide micro arrays for non model spe­
cies (Garcia­Reyero et al. 2008b). The technol­
ogy is constantly evolving, but there is one 
key question that must be addressed, whatever 
technology is in use: How do gene and protein 
expression and metabolite concentrations relate 
to ecological outcome? Progress has been made 
on this question, and initial studies on popu­
lation bases are now being published [see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.0900985.S1)]. Although biomarkers are 
valuable in regulatory and monitoring contexts, 
the meanings of such changes must be clari­
fied to allow efficient use in regulatory deci­
sion making (Adelman 2005; Boverhof and 
Zacharewski 2006).
Identifying sources of variation and mini­
mizing their effects. Variability in omics data 
is an ongoing concern, particularly in rela­
tion to multiple individual manipulations 
between biological sampling and data inter­
pretation. Workshop participants identified 
sources of technical and biological variation 
and recom mended how these should be 
managed in terms of experimental design 
[see Supplemental Material (doi:10.1289/
ehp.0900985.S1)]. Study design, inadequate 
sample numbers, and methods of sample 
acquisition, preparation, storage, processing, 
and analysis are key areas of possible technical 
artifacts. Major sources of variability include 
methods of normalization and statistical inter­
pretation. Careful study design is essential to 
minimize biological variability intra class (e.g., 
stage of reproduction in a control group), thus 
maximizing inter class differences (e.g., control 
vs. exposed groups). Interindividual variability 
within a population is essential for ecological 
health, and therefore an impact on such vari­
ability from a stressor can be very important.
Training and communication.  To 
advance the application of omics technology 
into regulatory ecotoxicology and water qual­
ity policy, effective scientific communication 
will be necessary among academia, industry, 
and regulators (Blunt et al. 2007). The ben­
efits and limitations of omics techniques need 
to be candidly discussed so that tools with 
the potentially greatest return on investment 
(both financial and knowledge based) may be 
prioritized for utilization. Multidisciplinary 
workshops allow continued dialogue to inform 
all stake holders of develop ments. These cross­
functional meetings also provide researchers 
with an understanding of the priorities of regu­
latory authorities to discover practical ways of 
solving issues.
Advances in omics have significant impli­
cations for risk assessment practice and regula­
tory decision making. The use of genomics 
technologies generates a large volume of data, 
and the field of bioinformatics is evolving rap­
idly to meet data analysis needs. A genom­
ics white paper (U.S. EPA 2004) identified 
areas likely to be influenced by omics. In that 
report, the Genomics Task Force recom­
mended that the agency develop training 
materials and modules to prepare risk assessors 
and decision makers who will be faced with 
the challenge of interpreting and applying 
omics information. Participants in the work­
shop described here also believed that training 
was critical for furthering the application of 
genomics technologies into monitoring and 
regulation, particularly as a means of interpret­
ing and applying genomics data for risk assess­
ment (Dearfield et al. 2008). Risk assessors 
must be able to communicate to managers 
and stakeholders both the underlying science 
and the interpretive tools and models used to 
develop the risk assessment. Likewise, it will 
be important to provide training to risk man­
agers regarding the benefits and limitations of 
genomics in risk assessments (Haymes et al. 
2009). 
There is also a need to build capacity 
within academia, the private sector, and gov­
ernment agencies to implement omic tools and 
to evaluate omics data, particularly with respect 
to biological and ecological significance. These 
institutions will require resources, support, and 
targeted training to bring scientists and deci­
sion makers within their organizations to a 
point where these tools can be used effectively 
in regulatory decision making, especially in 
risk assessment (U.S. EPA 2004). National 
and sub national programs and agencies should 
apply strategic hiring practices to recruit indi­
viduals who possess omics skills. It would be 
useful to develop and initiate training in the 
near future to enable risk assessors and risk 
managers to evaluate and incorporate omic data 
into environmental decision making. Initial 
training could address basic omics concepts, 
technologies, and potential applications and 
include the basic steps necessary to interpret 
and apply genomics data to risk assessment.
Research needs for regulatory implementa­
tion. Research needs were reviewed in two suc­
cessive Society of Environmental Toxicology 
and Chemistry Pellston workshops held in 
2004 and 2005 (Ankley et al. 2006, 2008b; 
Benson and Di Giulio 2007). These efforts 
identified both short­ and long­term needs 
that have not yet been fully addressed because 
of resource constraints.
The short­term needs identified were 
a) formal standardization and validation of 
data collection, analysis, and presentation for 
standard test species; and b) generation of 
libraries of gene expression, proteomic, or 
metabolite profiling data based on a set of ref­
erence chemicals with well­defined, relevant 
MOAs. As explained above, there have been 
important advances in recent years in the con­
text of both of these needs. The long­term 
needs identified were a) generation of genome 
sequence data for ecologically relevant species; 
and b) linkage of molecular and biochemical 
responses to adverse alterations in survival, 
growth and development, and reproduction.
Significant advances have also been made 
toward obtaining data for the develop ment of 
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reference gene expression profiling databases 
from species commonly used for regulatory 
assessments (Ankley et al. 2008b), although 
much work remains. Because toxico genomics 
data will be most valuable for predictive toxi­
cology and elucidating toxicologically rele­
vant MOAs for additional chemicals, a future 
database should be based on toxicity testing 
and monitoring protocols commonly used for 
regu latory purposes (e.g., global pesticide regis­
trations), as well as chemicals with well­known 
MOAs such as 17β­estradiol and dioxin.
Funding. Chemical production is highest 
in member countries of the Organisation for 
Economic Co­operation and Development 
(OECD), particularly in specialty chemicals and 
the life science sectors. Moreover, innovation in 
new chemical development and manufacturing 
practices is extremely high due to advances in 
combinatorial chemistry, nano technology, and 
bio technology. These changes question the sus­
tainability of current approaches to prioritiza­
tion, monitoring, and risk assessment. It may be 
difficult to allocate additional resources required 
to efficiently incorporate and understand omics 
data, but it is important for programs and agen­
cies to focus on these needs and to ensure that 
adequate funds and people are brought to bear 
on this need.
The OECD Environment, Health and 
Safety Program has started cooperative work 
for the use of genomic information for risk 
assessment of chemicals. The scope of this 
activity is to explore and evaluate regulatory 
application of genomic methods in chemical 
hazard/risk assessment. To reduce redundancy 
and minimize the funding to develop these 
omic technologies, international cooperation 
and a common database are essential. Target 
and cross­species omic information and 
technologies should be developed to moni­
tor animal species relevant to disparate coun­
tries. There are many international examples 
of initiatives to enhance eco toxico genomics, 
for example, the Ministry of Environment 
of Japan, the Canadian government’s 
Interdepartmental Genomics initiative, the 
U.S. EPA initiatives, and the U.K. Natural 
Environment Research Council Postgenomics 
and Proteomics research program.
A considerable investment in the gener­
ation and curation of appropriate reference 
exposure data is required to address the toxico­
genomics needs. For example, for most chemi­
cal regis trations, chronic aquatic toxicity data 
are required for one freshwater fish species 
(early life­stage toxicity), one freshwater inver­
tebrate species (full life­cycle toxicity), and, in 
most cases, one saltwater fish species (early life­
stage toxicity) and one saltwater invertebrate 
species (full life­cycle toxicity). This leads to a 
large number of Good Laboratory Practice–
compliant studies, and such a reference data­
base would likely require ~ $10 million over 
3–5 years. Although this is a substantial cost, a 
reference database is arguably the only means 
for successful and appropriate implementa­
tion of toxico genomics data into the current 
ecological risk assessment paradigm. Without a 
database to compare chemicals with unknown 
MOAs, the risk assessor will not be able to 
interpret the significance of the gene expres­
sion responses within the context of charac­
terizing ecological risk, because many gene 
expression changes are not anchored to adverse 
effect and risk assessment requires knowledge 
of the MOA and dose–response relationship. A 
good example of the utility of a comprehensive 
database is ToxRefDB, the Toxicity Reference 
Database (Martin et al. 2009), which contains 
mammalian toxicity data.
The most feasible way forward would be 
funding through a multi stakeholder consor­
tium, such as that achieved in the ACToR 
(Aggregated Computational Toxicology 
Resource) database (Judson et al. 2008). The 
final reference database would be open­source 
and accessible through a web site. The refer­
ence database could also be integrated into 
a tool similar to the U.S. Food and Drug 
Administration’s ArrayTrack to allow regula­
tory agencies to easily manage, analyze, and 
interpret omics data submitted by registrants 
or other government or academic laboratories 
using similar ecological species, testing proto­
cols, and microarray, proteomic, or metabolo­
mic platforms.
Conclusions
Omic technologies have advanced over recent 
years and continue to become more efficient, 
data­rich, and economical in use. Proof of 
principle has been achieved in terms of poten­
tial application to environmental toxicology, 
specifically the assessment of environ mental 
pollution impacts in nonmodel organisms. 
Increasing the use of omics technology in 
chemical risk assessment and environmental 
monitoring requires an expanded ecotoxico­
genomics reference database and a better 
understanding of the relationships between 
specific responses and biomarkers to ecologi­
cal adverse events. Through improved com­
munication between the sectors, the aim of 
assisting in regulatory decisions can be expe­
dited through the use of omic techniques.
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